Fenway Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.40 Cr
as on 31-12-2024
- Paid Up Capital ₹ 7.85 M
as on 31-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.00 Cr
as on 31-12-2024
About Fenway Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.40 Cr and a paid-up capital of Rs 7.85 M.
The company currently has active open charges totaling ₹5.00 Cr.
Akshay Navaladi and Ramesh Navaladi serve as directors at the Company.
- CIN/LLPIN
U24239DL2021PTC382105
- Company No.
382105
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2021
- Date of AGM
31 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fenway Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Navaladi  | Director | 09-Jun-2021 | Current |
| Ramesh Navaladi | Director | 09-Jun-2021 | Current |
Financial Performance of Fenway Pharmaceuticals.
Fenway Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Fenway Pharmaceuticals?
In 2022, Fenway Pharmaceuticals had a public holding of 36.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Disruptive Health Solutions Private LimitedActive 10 years 21 daysAkshay Navaladi and Ramesh Navaladi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2022 | ₹5.00 Cr | Open |
How Many Employees Work at Fenway Pharmaceuticals?
Fenway Pharmaceuticals has a workforce of 36 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fenway Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fenway Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
